Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

Since the few data exploring a possible association between Epstein–Barr virus (EBV) and breast cancer are conflicting, we investigated this association together with the influences of geographical areas. 509 breast cancers were sampled from areas with varying risks of nasopharynx carcinoma (NPC) such as North Africa (Algeria and Tunisia, high-risk area); southern France (Marseille, intermediate-risk area); and northern Europe (northern France, the Netherlands and Denmark; low-risk areas). Polymerase chain reaction (PCR) of a subregion of EBV BamHIC encoding the EBERs demonstrated that 31.8% of the tumours contained the viral genome. No significant differences were observed among the geographical areas. However, positive samples showed higher loads of the EBV genome in the NPC high- and intermediate-risk areas than in the low-risk areas. EBV type 1 was the dominant strain. In situ hybridization studies using a35S-labelled riboprobe for EBER1 and a laser capture microdissection, combined with quantitative PCR, showed that EBV localization was restricted to some tumour epithelial cell clusters. EBV could not be detected in the stroma. Considering the whole population covered, the presence of the EBV genome was not correlated with age, menopausal status, tumour, size, nodal status or histological grade. © 2001 Cancer Research Campaign

[1]  S. Glaser,et al.  Absence of Epstein‐Barr virus EBER‐1 transcripts in an epidemiologically diverse group of breast cancers , 1998, International journal of cancer.

[2]  O. Genoulaz,et al.  Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. , 1994, The Journal of general virology.

[3]  H. Frierson,et al.  Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  D. M. Parkin,et al.  Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ‐cell tumours , 1997, International journal of cancer.

[5]  H. Hausen Viruses in human cancers , 1991 .

[6]  F. Eschwège,et al.  Increased risk of nasopharyngeal carcinoma among males of french origin born in maghreb (north africa) , 1993, International journal of cancer.

[7]  L. Muenz,et al.  Clinical and prognostic features of a rapidly progressing breast cancer in tunisia , 1977, Cancer.

[8]  H. zur Hausen Viruses in human cancers. , 1991, Science.

[9]  D. Parkin,et al.  Cancer occurrence in developing countries , 1986 .

[10]  M. Ro̸rth,et al.  Organisation of the Danish adjuvant trials in breast cancer. , 1981, Danish medical bulletin.

[11]  D. Parkin,et al.  Cancer mortality among north African migrants in France. , 1996, International Journal of Epidemiology.

[12]  K. Aozasa,et al.  Carcinoma of stomach and breast with lymphoid stroma: localisation of Epstein-Barr virus. , 1994, Journal of clinical pathology.

[13]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[14]  L. Young,et al.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells , 1987, Journal of virology.

[15]  J. Foekens,et al.  DNA‐synthesis enzyme activity: A biological tool useful for predicting anti‐metabolic drug sensitivity in breast cancer? , 1997, International journal of cancer.

[16]  B E Griffin,et al.  Epstein-Barr virus in epithelial cell tumors: a breast cancer study. , 1995, Cancer research.

[17]  S. Bustin Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[18]  J. Hamner Carcinoma of the stomach. , 1952, Southern medicine and surgery.

[19]  D. Shibata,et al.  Description of an In Situ Hybridization Methodology for Detection of Epstein‐Barr Virus RNA in Paraffin‐Embedded Tissues, with a Survey of Normal and Neoplastic Tissues , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[20]  D. Larsimont,et al.  Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. , 1995, American journal of clinical pathology.

[21]  E. Altschuler Re: detection of Epstein-Barr virus in invasive breast cancers. , 1999, Journal of the National Cancer Institute.

[22]  I. Joab Response: Re: Detection of Epstein-Barr Virus in Invasive Breast Cancers. , 1999, Journal of the National Cancer Institute.

[23]  D. Birnbaum,et al.  Optimization of immunohistochemical detection of ERBB2 in human breast cancer: Impact of fixation , 1994, The Journal of pathology.

[24]  L. Ouafik,et al.  Developmental regulation of peptidylglycine alpha-amidating monooxygenase (PAM) in rat heart atrium and ventricle. Tissue-specific changes in distribution of PAM activity, mRNA levels, and protein forms. , 1989, The Journal of biological chemistry.

[25]  J. Iscovich,et al.  Cancer incidence in young offspring of Jewish immigrants to Israel. A methodological study. I. Nasopharyngeal malignancies and Ewing sarcoma. , 1990, Cancer detection and prevention.

[26]  L. Ouafik,et al.  Thyroid Hormone Regulation of Peptidylglycine α-Amidating Monooxygenase Expression in Anterior Pituitary Gland , 1990 .

[27]  K Hemminki,et al.  Re: detection of Epstein-Barr virus in invasive breast cancers. , 1999, Journal of the National Cancer Institute.

[28]  E. Kremmer,et al.  Detection of Epstein-Barr virus in invasive breast cancers. , 1999, Journal of the National Cancer Institute.